A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO)

BACKGROUND: Iron deficiency is frequent in haemodialysis (HD) patients with chronic kidney disease (CKD), and intravenous iron is an established therapy for these patients. This study assessed treatment routine, effectiveness, and safety of iron isomaltoside (IIM) 5% (Diafer®) in a HD cohort. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikhail, Ashraf I., Schön, Staffan, Simon, Sylvia, Brown, Christopher, Hegbrant, Jörgen B. A., Jensen, Gert, Moore, Jason, Lundberg, Lennart D. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327585/
https://www.ncbi.nlm.nih.gov/pubmed/30630452
http://dx.doi.org/10.1186/s12882-018-1159-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327585/
https://www.ncbi.nlm.nih.gov/pubmed/30630452
http://dx.doi.org/10.1186/s12882-018-1159-z

Ejemplares similares